The platform is established at the Institute for Clinical Chemistry and Laboratory Medicine of the University hospital Dresden and contributes to the mission of the NCT/UCC Dresden.
Alterations in cellular metabolism are a hallmark of many cancer types. Research in this context aims at understanding the role of cellular metabolism in tumorigenesis as well as developing new tumor metabolism-related therapies.
Metabolomics represent the comprehensive analysis of small molecules (i.e., metabolites) in body fluids, cells, tissues and tissue biopsies. Therefore, to facilitate research in cancer metabolism, the Metabolomics-Platform offers metabolite analysis based on complementary methods, specifically, Nuclear Magnetic Resonance (NMR) Spectroscopy and Mass Spectrometry (MS).